Literature DB >> 35615491

Expansion of Pharmacy Services During COVID-19: Pharmacists and Pharmacy Extenders Filling the Gaps Through Telehealth Services.

Catherine Liu1,2, Khusbu Patel3, Betsy Cernero4, Yuliya Baratt4, Nadine Dandan1, Olga Marshall1, Hanlin Li1, Leigh Efird4.   

Abstract

Purpose: The Coronavirus 2019 (COVID-19) pandemic created a significant disruption in healthcare. In our health-system located in New York City, the provision of care in the ambulatory care setting moved to a remote model virtually overnight. We describe interventions made during the pandemic to transform ambulatory care pharmacy through expansion of telehealth services. Summary: In March of 2020, the closure of primary care clinics and provider appointment cancellations due to inpatient redeployment created a void. Collaboration with other health care providers and development of standardized telehealth workflows served as a conduit for creating new roles and opportunities for pharmacy team members. Three main interventions where the pharmacy team filled gaps include; (1) Expansion of pharmacist telemedicine visits for high-risk patients to improve access to primary care visits, (2) Partnership with nursing to create a centralized refill call center workflow, (3) Integration of pharmacy extenders into the prior authorization process to prevent medication access issues. Existing collaborative practice agreements for chronic disease management were utilized. A virtual pharmacist model for patient care contributed to an increase in telehealth visits from 51 in 2019 to 2997 total visits in 2020. In addition, the health-system refill call center expanded its services through collaboration with our pharmacy team. Pharmacists and pharmacy interns partnered with nurse practitioners to improve the call center workflow and address the significant increase in refill requests during the outbreak. Furthermore, a prior authorization process was created across multiple ambulatory care clinics to expedite medication access and prevent delays in therapy.
Conclusion: Our ambulatory care pharmacy team leveraged technology, innovative workflows, and collaborative teamwork to catalyze a shift in pharmacists' and pharmacy extenders' roles in healthcare delivery to expeditiously meet patients' needs during a pandemic.
© The Author(s) 2021.

Entities:  

Keywords:  ambulatory services; ambulatory services - prescription service; clinical services; medication Process; medication therapy management; technicians

Year:  2021        PMID: 35615491      PMCID: PMC9125115          DOI: 10.1177/00185787211032360

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  8 in total

1.  Using an Electronic Medication Refill System to Improve Provider Productivity in an Accountable Care Setting.

Authors:  Robert Schoenhaus; Adam Lustig; Silvia Rivas; Victor Monrreal; Kimberly D Westrich; Robert W Dubois
Journal:  J Manag Care Spec Pharm       Date:  2016-03

2.  Examining the prior authorization process, patient outcomes, and the impact of a pharmacy intervention: A single-center review.

Authors:  Sabrina Popatia; Kelsey S Flood; Nicole M Golbari; Parth V Patel; Suzanne M Olbricht; Alexa B Kimball; Martina L Porter
Journal:  J Am Acad Dermatol       Date:  2019-05-16       Impact factor: 11.527

3.  Development and implementation of a centralized comprehensive refill authorization program in an academic health system.

Authors:  Matthew H Rim; Karen C Thomas; Brittanie Hatch; Michael Kelly; Linda S Tyler
Journal:  Am J Health Syst Pharm       Date:  2018-02-01       Impact factor: 2.637

4.  Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension.

Authors:  Steven M Smith; Nicholas W Carris; Eric Dietrich; John G Gums; Liz Uribe; Christopher S Coffey; Tyler H Gums; Barry L Carter
Journal:  J Am Soc Hypertens       Date:  2016-01-18

5.  Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial.

Authors:  Jan D Hirsch; Neil Steers; David S Adler; Grace M Kuo; Candis M Morello; Megan Lang; Renu F Singh; Yelena Wood; Robert M Kaplan; Carol M Mangione
Journal:  Clin Ther       Date:  2014-07-30       Impact factor: 3.393

6.  Management of patients with type 2 diabetes by pharmacists in primary care clinics.

Authors:  E A Coast-Senior; B A Kroner; C L Kelley; L E Trilli
Journal:  Ann Pharmacother       Date:  1998-06       Impact factor: 3.154

7.  Outcomes of a pharmacist-managed medication refill program.

Authors:  Sarah J Billups; Thomas Delate; Carey Newlon; Sarah Schwiesow; Renee Jahnke; Ann Nadrash
Journal:  J Am Pharm Assoc (2003)       Date:  2013 Sep-Oct

8.  Physician-pharmacist co-management and 24-hour blood pressure control.

Authors:  Ziqian Chen; Michael E Ernst; Gail Ardery; Yinghui Xu; Barry L Carter
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-02-12       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.